Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-17 Purchase |
2022-08-18 3:56 pm |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
600,000 | $0.172 | $103,200 | 780,232 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-28 Option Award |
2024-07-02 6:06 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
4,854 | $2.958 | 31,362 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:31 pm |
N/A 2034-06-24 |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:17 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
167 | $1.717 | 26,508 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 4:05 pm |
N/A N/A |
Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
167 | $1.5895 | 26,341 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.0876 | 785,232 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-15 4:30 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.748 | 180,232 (Direct) |
View |
| 2022-05-12 Exercise |
2022-05-16 1:39 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
100,000 | $1 | 245,232 (Direct) |
View |
| 2022-05-12 Exercise |
2022-05-16 1:39 pm |
N/A 2029-09-05 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
100,000 | $0 | 245,232 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:14 pm |
N/A 2032-03-01 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:17 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
3,623 | $1.6575 | 75,232 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $1.9465 | 71,609 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-27 4:13 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $1.5 | 66,609 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-27 4:13 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0 | 66,609 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:58 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.4521 | 361,609 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:58 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 361,609 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 5:20 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.448 | 56,609 (Direct) |
View |